STOCK TITAN

Travelers Companies (NYSE: TRV) CFO sells 14,037 shares after option exercises

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Travelers Companies, Inc. EVP & Chief Financial Officer Daniel S. Frey reported option-related trades on July 21, 2026. He exercised stock options for a total of 14,037 shares of common stock at strike prices of $139.83 and $172.50 per share, acquired the underlying shares, and sold 11,037 shares at a weighted-average price of $368.1641 (range $368.11–$368.45) and 3,000 shares at $368.5250 in open market or private transactions.

Positive

  • None.

Negative

  • None.
Insider Frey Daniel S.
Role EVP & Chief Financial Officer
Sold 14,037 shs ($5.17M)
Approx. gross sale proceeds $5.17M
Approx. exercise cost $2.06M
Approx. pre-tax spread $3.11M
Type Security Shares Price Value
Exercise Stock Options (Right to Buy) 11,037 $0.00 $0.00
Exercise Stock Options (Right to Buy) 3,000 $0.00 $0.00
Exercise Common Stock 11,037 $139.83 $1.54M
Sale Common Stock F1 11,037 $368.1641 $4.06M
Exercise Common Stock 3,000 $172.50 $518K
Sale Common Stock 3,000 $368.525 $1.11M
Holdings After Transaction: Stock Options (Right to Buy) — 22,205 shares (Direct); Common Stock — 27,534.948 shares (Direct)
Footnotes (1)
  1. F1. Represents the weighted average sales price for increments ranging from $368.11 to $368.45. The Reporting Person undertakes to provide upon request by the Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Shares sold (first tranche) 11,037 shares Common stock sale on July 21, 2026 in open market or private transaction
Weighted-average sale price (first tranche) $368.1641 per share Weighted average for prices ranging from $368.11 to $368.45
Shares sold (second tranche) 3,000 shares Common stock sale on July 21, 2026 in open market or private transaction
Sale price (second tranche) $368.5250 per share Price per share for 3,000-share sale on July 21, 2026
Options exercised (first grant) 11,037 shares at $139.83 Stock options (Right to Buy) exercised into common stock
Options exercised (second grant) 3,000 shares at $172.50 Stock options (Right to Buy) exercised into common stock
Total shares sold 14,037 shares Net shares sold per transaction summary for July 21, 2026
Stock Options (Right to Buy) financial
"security_title: Stock Options (Right to Buy)"
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
weighted average sales price financial
"Represents the weighted average sales price for increments ranging"
open market or private transaction financial
"Sale in open market or private transaction"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did TRV CFO Daniel S. Frey report in this Form 4?

Daniel S. Frey, CFO of Travelers Companies (TRV), reported exercising stock options for 14,037 shares and selling the resulting common stock on July 21, 2026 in open market or private transactions at prices around $368 per share.

How many Travelers (TRV) shares did the CFO sell and at what prices?

The CFO sold 11,037 shares at a weighted-average price of $368.1641 (range $368.11–$368.45) and an additional 3,000 shares at $368.5250, all on July 21, 2026, according to the insider filing.

How many stock options did TRV’s CFO exercise in this transaction?

He exercised stock options covering a total of 14,037 shares of Travelers common stock, including 11,037 options with a strike price of $139.83 and 3,000 options with a strike price of $172.50, then sold the acquired shares.

Were the Travelers (TRV) CFO’s sales tied to option exercises?

Yes. The Form 4 shows that Daniel S. Frey exercised stock options for 14,037 shares at strike prices of $139.83 and $172.50, and on the same date sold all 14,037 resulting shares in open market or private transactions.

Did the TRV Form 4 indicate the CFO used a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is not marked as affirmative, and the only footnote provided relates to the weighted average sales price. It does not state that these trades were made under a Rule 10b5-1 trading plan.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Frey Daniel S.

(Last)(First)(Middle)
THE TRAVELERS COMPANIES, INC.
385 WASHINGTON STREET

(Street)
ST. PAUL MINNESOTA 55102

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
TRAVELERS COMPANIES, INC. [ TRV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP & Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/21/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/21/2026M11,037A$139.8338,571.948D
Common Stock07/21/2026S11,037D$368.1641(1)27,534.948D
Common Stock07/21/2026M3,000A$172.530,534.948D
Common Stock07/21/2026S3,000D$368.52527,534.948D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options (Right to Buy)$139.8307/21/2026M11,03702/02/202402/02/2031Common Stock11,037$00D
Stock Options (Right to Buy)$172.507/21/2026M3,00002/08/202502/08/2032Common Stock3,000$022,205D
Explanation of Responses:
1. Represents the weighted average sales price for increments ranging from $368.11 to $368.45. The Reporting Person undertakes to provide upon request by the Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
/s/ Wendy C. Skjerven, by power of attorney07/23/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)